|
| |
| |
| |
|
| |
| |
|
| |
| |
|
| ENDOCRINE PROGRAMS |
- Peptide covalently bound to MAb for diabetes indication (Biologic)
- DPP4 inhibitor for diabetes indication (Small Molecule)
- Cell therapy/implantable device for treatment of diabetes (Combination Biologic/Device)
|
| |
| DERMATOLOGY PROGRAMS |
- Small molecule treatment for psoriasis (Small Molecule)
|
| |
|
CARDIOVASCULAR PROGRAM |
- Gene-based therapeutic for peripheral limb ischemia (Biologic)
- Gene-based therapeutic for coronary artery disease (Biologic)
- Recombinant protein for treatment of heart disease (Biologic)
|
| |
| HEMATOLOGY PROGRAM |
- Gene-based therapeutic for clotting Factor IX deficiency (Biologic)
|
| |
| ONCOLOGY PROGRAMS |
- Peptide covalently bound to MAb (Biologic)
- Genetically modified autologous dendritic cells with small molecule activator for treatment of prostate cancer. (Combination Biologic/Drug)
- Transgenic lymphocyte immunization for treatment of solid tumors. (Biologic)
- Genetically modified donor lymphocyte infusion with small molecule activator for treatment of Graft-vs-Host Disease in hematologic malignancy (Combination Biologic/Drug)
|
| |
| INFECTIOUS DISEASE VACCINE PROGRAMS |
- Master File for production of adenoviral vector (Biologic)
-
Vaccines based on genetically modified parasite, and on antigen expressing plasmid vectors
|
|
|
|
|
| |
|
| |
|
|
|
|
|
|
| Copyright@2011 Conventus BioMedical Solutions, Inc. |
|
| |
|
